Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPACT: Adverse Provider Conditions on Medical Decision-Making
NCT07842367Phase 2Recruiting
- Sponsor
- University of Arkansas
- Start
- Sep 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
A Phase 2 trial of influenza vaccine, sponsored by University of Arkansas. Started Sep 2026; status: recruiting.
02
Drugs
influenza vaccine
Beyond the preview
Go deeper on NCT07842367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07842367.